Alfa joined Silverfleet Capital in 2002, and is responsible for the firm’s investment activities in the healthcare sector having been involved in several successful investments, including Phadia and Sterigenics.

Alfa was also previously responsible for the origination of new investment opportunities in the Nordic region, and was involved with the firm’s investments in Phase One and Cimbria.

Before joining Silverfleet, Alfa was an analyst at CSFB Private Equity and prior to that, DLJ/CSFB's leveraged finance team in London.

Alfa graduated with a BSc in Mathematics and Economics from the University of Warwick, before completing a Masters in Finance at Cambridge University.